Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,196 | -2,417 | -3,489 | -4,341 | -2,071 |
| Depreciation Amortization | 351 | 205 | 215 | 215 | 411 |
| Accounts receivable | -7 | 6 | -3 | 16 | -22 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 122 | N/A |
| Other Working Capital | 989 | 1,003 | -105 | 548 | 78 |
| Other Operating Activity | 795 | 84 | 1,636 | 1,961 | 12 |
| Operating Cash Flow | $-1,068 | $-1,119 | $-1,746 | $-1,479 | $-1,592 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | N/A | N/A | -31 | -14 |
| Investing Cash Flow | $-2 | $0 | $N/A | $-31 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 748 | 587 | N/A | N/A | 1,646 |
| Debt Repayment | -540 | -477 | -412 | -540 | -1,468 |
| Common Stock Issued | 567 | 835 | 436 | 3,720 | N/A |
| Other Financing Activity | -30 | -29 | 0 | 0 | 1,889 |
| Financing Cash Flow | $745 | $916 | $24 | $3,180 | $2,067 |
| Beginning Cash Position | 388 | 591 | 2,313 | 643 | 182 |
| End Cash Position | 63 | 388 | 591 | 2,313 | 643 |
| Net Cash Flow | $-325 | $-203 | $-1,722 | $1,670 | $461 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,068 | -1,119 | -1,746 | -1,479 | -1,592 |
| Capital Expenditure | -2 | 0 | N/A | -31 | -14 |
| Free Cash Flow | -1,070 | -1,119 | -1,746 | -1,510 | -1,606 |